Key takeaways

  • First-trimester combined screening = dual marker blood test (PAPP-A + free beta-hCG) plus an NT scan, done strictly between 11+0 and 13+6 weeks.
  • It is a screening test for three chromosomal conditions (trisomy 21, 18, 13) and gives a risk number like 1 in 250, not a diagnosis.
  • FOGSI and global guidelines now offer screening to all pregnant women regardless of age; the old 'only over 35' rule is outdated.
  • A high-risk result usually does NOT mean an affected baby. Even at 1 in 50, that is a 2% chance, so most high-risk results are false alarms.
  • Next steps after high risk are NIPT (more accurate, non-invasive) or a diagnostic test (CVS or amniocentesis) for a definite answer.
  • Cost is roughly 4,000-8,000 in private centres for the combined package, and it is free or subsidised at many government hospitals.

What the combined first-trimester screening measures

The test screens for the three most common chromosomal trisomies seen in pregnancy. Down syndrome (trisomy 21) is the most common, with a background chance of about 1 in 700 to 1 in 1,000 at younger ages, rising to roughly 1 in 100 by age 40. Trisomy 18 (Edwards) and trisomy 13 (Patau) are much rarer and usually far more severe; most affected pregnancies sadly end in Miscarriage: Types, Recovery and Care in India or stillbirth.

The screening has two parts that are combined into a single risk number.

The dual marker blood test. A simple blood draw measures two placental proteins. PAPP-A (pregnancy-associated plasma protein A) tends to be lower in affected pregnancies. Free beta-hCG tends to be higher in trisomy 21 and lower in trisomy 18 and 13. No fasting is needed, and results usually take 3-7 days.

The NT scan. Nuchal translucency is a fluid-filled space at the back of the baby's neck, measured on ultrasound. An increased NT (broadly above about 3 mm, or above the 95th percentile for the gestation) raises the chance of trisomy 21, 18 and 13 as well as congenital heart disease and some genetic syndromes. The measurement needs a trained, certified operator (Fetal Medicine Foundation accreditation is the standard), so it is best done at a fetal medicine unit. Many centres also check the nasal bone, which is often absent or underdeveloped in trisomy 21. Advanced units may add ductus venosus flow, tricuspid regurgitation and the facial angle to fine-tune the result.

Why it is offered, and the choice that is yours

Current guidance from FOGSI and global obstetric bodies is that chromosomal screening should be offered to every pregnant woman, whatever her age. The old rule of only screening women 35 and over is outdated. Although individual risk rises with age, most Down syndrome pregnancies happen in younger women simply because there are far more of them, so an age-based rule misses the majority of affected pregnancies.

Whether to do the screening is entirely your decision, ideally made with your partner. The most useful question to ask beforehand is: if the result is high risk and a diagnostic test confirms a condition, what would we do? Both continuing and considering termination are valid, legal choices in India.

Some couples decline screening altogether because they would continue regardless and would rather not carry the worry. That too is respected. Others want the information purely to prepare, choosing the right delivery hospital, arranging newborn care and getting the family ready. Couples who might consider ending the pregnancy need the result early enough to act within India's legal medical termination window.

Where budget allows, many urban couples now choose NIPT as a first-line screen because it is far more accurate. Even then, the NT scan is often still done, because a raised NT also flags heart and other conditions that NIPT does not detect. A clear, unhurried conversation with your OB at booking helps you decide what fits your situation.

Timing and what to expect on the day

The window is 11+0 to 13+6 weeks, dated from your last period or an earlier dating scan. This timing is not flexible: too early and the markers do not separate affected from unaffected pregnancies well; too late and the test is no longer valid. The sweet spot is around 12 to 13 weeks.

Booking. Most fetal medicine clinics, private hospital antenatal departments and large pathology chains offer the combined screen as a package. The blood test and the scan can be done the same day at one centre, or on separate days, as long as both fall within the window.

The blood test is an ordinary venous sample, no fasting required. The NT scan is usually a transabdominal ultrasound (you may be asked to come with a comfortably full bladder), occasionally transvaginal if the view is unclear. It takes about 20-30 minutes, and the sonographer may need patience to catch the baby in the exact position for an accurate measurement.

Your report combines the blood values, NT, age, weight and gestation into a '1 in N' risk for each trisomy. It should also list the raw numbers, the PAPP-A and free beta-hCG as MoM (multiples of the median) and the NT in mm. Your OB then explains what it means.

What a low-risk result means

A low-risk result means the calculated chance of trisomy 21, 18 and 13 is below your lab's cut-off (often 1 in 250 or 1 in 300). For most pregnancies this is reassuring, and no further chromosomal testing is recommended in the routine pathway.

A few honest caveats are worth holding in mind:

  • The test only screens for those three trisomies. It does not pick up other chromosomal problems, single-gene disorders (such as thalassemia, sickle cell, cystic fibrosis or fragile X), structural birth defects or conditions like autism. Concerns about inherited single-gene conditions are better addressed through carrier screening and genetic counselling.
  • About 10-15% of Down syndrome pregnancies still screen low risk. Couples who want extra reassurance can add NIPT as a second screen.
  • The NT measurement matters in its own right. An NT above 3.5 mm, even with a low overall risk, is linked to congenital heart disease and some syndromes and usually warrants a detailed fetal echocardiogram at 20-22 weeks. Ask your OB to review the actual NT, not just the headline risk.

For most low-risk pregnancies, the next steps are simply the rest of the routine pathway: the anomaly (TIFFA) scan at 18-22 weeks, the oral glucose tolerance test at 24-28 weeks, and the usual antenatal visits. First-trimester screening is the start of the screening journey, not the whole of it.

What a high-risk result means, and the next steps

A high-risk result means the calculated chance is at or above your lab's cut-off. This is frightening to read, so the single most important point comes first: high risk does not mean a confirmed diagnosis. The reported number is the actual probability. A result of 1 in 50 is a 2% chance, meaning 49 of every 50 babies with that result do not have the condition. Most high-risk results turn out to be false alarms.

There are two main next steps, and your OB or a fetal medicine specialist will help you choose.

NIPT as a second screen. NIPT is non-invasive (just a blood test, no risk to the pregnancy) and very accurate. If it is also positive, the chance of an affected baby is high and a diagnostic test is then offered to confirm. If it is negative, the original high-risk result is essentially explained as a false positive, though a raised NT may still need a detailed heart and anatomy scan.

Diagnostic testing gives a definite answer:

  • CVS (chorionic villus sampling) samples placental tissue, usually at 11-14 weeks. Pregnancy-loss risk is about 0.5-1% in experienced hands.
  • Amniocentesis samples amniotic fluid, usually from 15-18 weeks, with a lower loss risk of about 0.1-0.3%.

CVS is done earlier, so it gives answers sooner, which matters if termination is a consideration and time within the legal window is short. Amniocentesis is done a few weeks later but carries slightly lower risk. The right choice depends on your gestation when the result arrives, your preference for earliest answer versus lowest risk, and which experienced operators are available locally.

The conversation after a high-risk result is one of the hardest in antenatal care. A good counsellor will go through the real number, the testing options, the timeline, what a confirmed diagnosis would mean, and the support for either continuing or ending the pregnancy. Looking after your mental health here is not optional, and support is covered below.

The Indian MTP context: what the law allows

If a diagnosis is confirmed and a couple wishes to consider termination, the framework is the Medical Termination of Pregnancy (MTP) Act 1971, as amended in 2021. Understanding the timeline helps you plan when to screen.

  • Up to 20 weeks: termination is allowed on the opinion of one registered medical practitioner, including where there is substantial risk of serious fetal abnormality.
  • 20 to 24 weeks: permitted on the opinion of two practitioners for specific categories, which include substantial fetal abnormality.
  • Beyond 24 weeks: allowed only for substantial fetal abnormality with approval from a state Medical Board, a slower process reserved for the most severe situations.

Why timing of the screen matters. The combined screen is done at 11-13+6 weeks; results take 3-7 days; a follow-up NIPT adds 7-10 days; CVS can be done at 11-14 weeks and amniocentesis from 15 weeks. The full pathway after a high-risk result can take two to six weeks. Started early in the window (around 11 weeks), it usually completes with time to spare inside the 20-week window. Started at the very end (13+6 weeks), the timeline is tight.

So couples who would consider termination of a confirmed serious condition are generally advised to screen at the earlier end of the window, or to choose NIPT (possible from 10 weeks) for the earliest possible answer. For couples who would continue regardless, there is no time pressure and the information is used purely to prepare. These decisions carry real emotional and ethical weight, deserve unhurried support, and remain the couple's own to make under both medical and legal protection.

Where to get the test in India, and what it costs

The combined screen is widely available, but quality varies, and the choice of centre matters most for the NT scan, which depends on operator certification.

The dual marker blood test is offered by major pathology chains including Dr Lal PathLabs, Metropolis, Thyrocare, SRL, Apollo Diagnostics and others. As a standardised blood test, quality is fairly consistent across providers. Cost is roughly 2,000-4,000 for the dual marker alone.

The NT scan and combined calculation are where the provider really counts. Accurate NT measurement needs an FMF-certified operator, calibrated equipment and validated software. Many general radiology and obstetric units offer NT scans without this certification, so quality varies. Dedicated fetal medicine units, found across the major metros and most tier-2 cities, give the highest-quality measurements and risk calculations.

Government access. The combined screen is available at major government tertiary hospitals (such as AIIMS, PGIMER and JIPMER) and many state medical colleges, often free or heavily subsidised. State antenatal programmes increasingly include first-trimester screening; your ASHA worker or local antenatal clinic can guide you on what is covered in your state.

Cost summary (private): dual marker alone roughly 2,000-4,000; NT scan alone roughly 2,000-4,000 (more at specialised units); the combined package roughly 4,000-8,000. Free or subsidised at government centres.

Understanding the individual markers

The combined risk is the headline, but the individual markers carry meaning of their own, which matters when results are unusual.

PAPP-A rises through pregnancy. It tends to be low in trisomy pregnancies (often below 0.4 MoM is flagged as low). Importantly, low PAPP-A is also linked, even with normal chromosomes, to growth restriction, Preeclampsia in Pregnancy: High BP, Warning Signs and Care, preterm birth and stillbirth. Some OBs use a low PAPP-A as a reason for closer monitoring later in pregnancy.

Free beta-hCG tends to be high in trisomy 21 and low in trisomy 18 and 13. A very high level in early pregnancy can occasionally point to other issues, including a molar pregnancy.

Nuchal translucency is normally under about 3 mm at this gestation. The higher it is, the higher the overall risk, and a markedly raised NT (above about 6 mm) is associated with substantial risk of chromosomal or structural abnormality even when the chromosomes turn out normal, including conditions such as Noonan, Turner and skeletal dysplasias.

Nasal bone is normally visible by about 12 weeks. It is absent in roughly 60% of trisomy 21 fetuses at this stage, compared with about 2% of unaffected fetuses, so it is most useful for refining borderline results.

The practical takeaway: when an individual marker is clearly abnormal even though the combined risk reads low, it still deserves attention. An NT of 4 mm, for instance, may still produce a below-cut-off combined risk but warrants a closer look because of its non-chromosomal links. Always ask your OB or fetal medicine specialist to read the actual numbers, not just the low-or-high label. For the bigger picture on how these soft markers fit together, see our guide to birth-defects screening and soft markers.

Counselling, decisions and looking after yourself

Good counselling, both before and after the test, makes a real difference, and it is often under-provided in Indian practice. It is reasonable to ask for it.

Before the test, your OB should explain what it screens for (only trisomy 21, 18, 13), what it cannot detect, the difference between screening and diagnosis, the false-positive and false-negative rates, and what a high-risk result would lead to. You should have time to decide whether you even want the test.

After a low-risk result, the message is usually brief and reassuring, with the routine pathway continuing and the caveat that low risk is not a guarantee against every condition.

After a high-risk result, the conversation needs sensitivity, time and accurate numbers. The actual probability should be stated plainly, the follow-up options explained with their timelines and costs, and the implications of a confirmed diagnosis discussed honestly, including both the support for continuing and the option of termination. You should be given time to talk things over privately and with family before deciding.

Genetic counsellors are trained specifically for this. India's workforce is small but growing, concentrated in major fetal medicine centres and tertiary hospitals. A consultation (roughly 1,000-3,000) adds real value for high-risk results, a family history of genetic conditions, recurrent loss, or decisions about NIPT versus invasive testing. Our guide to prenatal genetic counselling explains what to expect.

This is an anxious time, and that is normal. The waiting between a screen and a confirmatory test is one of the hardest stretches of pregnancy. If worry becomes overwhelming, perinatal anxiety and depression are common and treatable. National support lines include iCall (9152987821), Vandrevala Foundation (1860-2662-345) and the government Tele MANAS line (14416). Peer support from others who have navigated similar results can also help.

Dual marker vs NIPT vs quadruple test: a practical guide

Indian couples often weigh up several options. Here is how they compare on accuracy, timing and cost.

When to see a doctor

First-trimester screening is itself part of routine care, so the main action is simply to book it within the 11-13+6 week window. Beyond that, reach out to your OB or fetal medicine unit promptly if:

First-trimester screening myths in India, corrected

Myth: Only women over 35 need chromosomal screening

  • False, and outdated. Although risk rises with age (around 1 in 1,000 at 25, 1 in 250 at 35, 1 in 100 at 40), most Down syndrome pregnancies occur in younger women simply because there are far more pregnancies at younger ages.
  • Current FOGSI and global guidance offers screening to all pregnant women, whatever their age. The decision to take it up is yours, based on what you would do with the result.

Myth: A high-risk result means the baby definitely has Down syndrome

  • False, and the most important point to understand. The reported number is the actual probability: 1 in 50 means a 2% chance, so 49 of 50 babies with that result are unaffected.
  • The next step is NIPT or a diagnostic test (CVS or amniocentesis) to confirm or rule it out. Focus on the real number, not the alarming label.

Myth: A low-risk result guarantees a healthy baby

  • False. It reassures only about the three trisomies tested. It does not detect other chromosomal problems, single-gene disorders, structural defects or conditions like autism.
  • About 10-15% of Down syndrome pregnancies still screen low risk. The anomaly (TIFFA) scan at 18-22 weeks, carrier screening and NIPT each cover different gaps.

Myth: The screening can be done any time in pregnancy

  • False. It only works within 11+0 to 13+6 weeks. Too early and the markers do not separate well; too late and the test is invalid.
  • Miss the window and the options are the second-trimester quadruple test (lower detection) or NIPT (possible from 10 weeks and later). Plan ahead and book early in the window.

Frequently asked questions

Is the dual marker test compulsory in pregnancy?

No. Chromosomal screening is offered to every pregnant woman, but taking it is your choice. Some couples decline it because they would continue the pregnancy whatever the result. The decision is best made with your OB after understanding what the test can and cannot tell you.

My result is 1 in 100. Should I be worried?

1 in 100 is classed as high risk, but it means a 1% chance, so 99 of 100 babies with that result are unaffected. It is a signal to do further testing (NIPT, or a diagnostic CVS or amniocentesis), not a diagnosis. Ask your OB to walk you through the options and timeline.

Should I do the dual marker or NIPT?

If cost allows, NIPT is more accurate (over 99% detection for Down syndrome versus 85-90% for the dual marker) and can be done from 10 weeks. The dual marker plus NT scan is the cheaper, widely available standard. Many couples do NIPT with an NT scan added, since the NT also flags heart conditions NIPT cannot see.

Does the dual marker test require fasting?

No fasting is needed. It is an ordinary blood draw and can be done at any time of day, ideally on the same visit as your NT scan within the 11-13+6 week window.

What does a low PAPP-A mean if my chromosomal risk is low?

A low PAPP-A with a normal chromosomal screen is linked to a higher chance of issues later in pregnancy, such as growth restriction or preeclampsia. It is not a cause for panic, but your OB may recommend closer growth monitoring and, in some cases, low-dose aspirin. Discuss your specific numbers with them.

Is the NT scan still useful if I have already done NIPT?

Yes. NIPT is excellent for the common trisomies but does not assess the baby's structure. A raised NT can flag congenital heart disease and other conditions NIPT does not detect, which is why many centres recommend NIPT plus an NT scan when the budget allows.

Sources